TY - JOUR AU - Zarogoulidis, Paul AU - Papadopoulos, Vasilis AU - Maragouli, Elena AU - Papatsibas, George AU - Huang, Haidong PY - 2017 TI - Checkpoint inhibitors in metastatic epidermal growth factor receptor-mutated non-small cell lung cancer patients: where we treating the wrong cancer? JF - Journal of Thoracic Disease; Vol 9, No 9 (September 27, 2017): Journal of Thoracic Disease Y2 - 2017 KW - N2 - Tyrosine kinase inhibitors (TKIs) is the best treatment choice for patients with epidermal growth factor receptor mutation (EGFR) (1). UR - https://jtd.amegroups.org/article/view/15167